|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
EBSCO_ocn969642094 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
161014s2017 nyu ob 001 0 eng |
| 010 |
|
|
|a 2020677239
|
| 040 |
|
|
|a DLC
|b eng
|e rda
|c DLC
|d N$T
|d YDX
|d OCLCF
|d AGLDB
|d IGB
|d AUW
|d BTN
|d MHW
|d INTCL
|d SNK
|d G3B
|d S8I
|d S8J
|d S9I
|d STF
|d D6H
|d EBLCP
|d OCLCO
|d OCLCQ
|d OCLCO
|
| 019 |
|
|
|a 966445398
|a 973741701
|a 973805438
|
| 020 |
|
|
|a 9781536104455
|q (ebook)
|
| 020 |
|
|
|a 1536104450
|
| 020 |
|
|
|z 9781634858496
|q (softcover)
|
| 020 |
|
|
|z 1634858492
|
| 035 |
|
|
|a (OCoLC)969642094
|z (OCoLC)966445398
|z (OCoLC)973741701
|z (OCoLC)973805438
|
| 050 |
0 |
0 |
|a RC268.5
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 082 |
0 |
0 |
|a 616.99/40072
|2 23
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a Advances in carcinogenesis research /
|c Masayoshi Yamaguchi, editor.
|
| 264 |
|
1 |
|a New York :
|b Nova Biomedical,
|c [2017]
|
| 300 |
|
|
|a 1 online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Cancer Etiology, Diagnosis and Treatments
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
|
|
|a Description based on print version record.
|
| 505 |
0 |
|
|a Preface; Bidirectional Crosstalk between Estrogen Signaling Pathways and DNA Repair Machinery; Abstract; Introduction; Milestones on the Route Leading to the Recognition of Correlation between Hormonal Signaling and Genomic Stability; Age and Gender Related Differences in the Prevalence of Oral Cancer Suggest a Crucial Role of Defective Female Hormal Mechanism in Cancer Risk; Increased Female to Male Ratio of Excessive Cancer Risk in Northen Geographic Regions Is in Correlation with Darkness Related Femal Hormonal Deficiency.
|
| 505 |
8 |
|
|a Defective Estrogen Signaling Induces Insulin Resistance and Its Comorbidities: Cardiovascular Diseases and MalignanciesBidirectional Crosstalk between Estrogen Signaling Pathways and DNA Repair Machinery; Mutual Upregulation between Estrogen Receptor Signaling and DNA Controlling Activity of BRCA-Protein; Estrogen Signaling Promotes the Expression and Activity of Tumor Suppressor p53 Gene; Interplay between Estrogen Signaling and PTEN during Cell Proliferation; PALB2 Protein Has Important Role in Genome Stabilization in Strong Correlation with BRCA Proteins.
|
| 505 |
8 |
|
|a Crosstalk between Estrogen Signaling and other Hormonal Mechanisms for the Upregulation of Genome Stabilizer MachineryAntiestrogen Use Is a Medical Mistake; Molecular Mechanisms of the Transient Upregulation of Estrogen Signaling by Antiextrogen Treatment; Conclusion; References; Regucalcin Plays a Crucial Role as a Suppressor in Carcinogenesis; Abstract; Introduction; Suppressive Role of Regucalcin in Cell Proliferation; Regucalcin Suppresses Manifold Pathways of Cell Signaling; Regucalcin Suppresses Cell Proliferation; Suppressive Role of Regucalcin in Carcinogenesis of Animal Models.
|
| 505 |
8 |
|
|a Regucalcin Is Involved in the Depression of Liver RegenerationInvolvement of Regucalcin in Human Hepatocarcinogenesis; Involvement of Reguclcin in Various Human Cancers; Regucalcin Gene Expression Is Suppressed in Various Cancer Tissues; Involvement of Regucalcin in Lung Cancer Cells; Involvement of Regucalcin in Breast Cancer Cells; Involvement of Regucalcin in Prostate Cancer Cells; Involvement of Regucalcin in Kidney Cancer Cells; Involvement of Regucalcin in Pancreatic Cancer Cells; Higher Regucalcin Gene Expression Prolongs Survival of Cancer Patients; Prospect; References.
|
| 505 |
8 |
|
|a Alternative Way to Inhibit STAT3 Signaling in Gastric CancerAbstract; Introduction; STAT3 Signaling in Gastric Cancer; STAT3 Inhibition in Gastric Cancer; ; Current State and Limitations; SHP-1: A Promising Phosphatase to Inactivate STAT3; Induction of SHP-1 to Inhibit STAT3 Signaling; Future Perspectives; Conclusion; References; Colorectal Cancer in Patients with Inflammatory Bowel Disease; Abstract; Introduction; Epidemiology; Risk of CRC in CD; Risk of CRC in UC; Mortality of CRC in IBD; Risk Factors for CRC in IBD Patients; Age at Onset of IBD; Disease Extent; Duration of Disease.
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Carcinogenesis.
|
| 650 |
|
2 |
|a Carcinogenesis
|
| 650 |
|
6 |
|a Cancérogenèse.
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a Carcinogenesis
|2 fast
|
| 700 |
1 |
|
|a Yamaguchi, Masayoshi,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t Advances in carcinogenesis research
|d New York : Nova Biomedical, [2017]
|z 9781634858496 (softcover)
|w (DLC) 2016956790
|
| 830 |
|
0 |
|a Cancer etiology, diagnosis, and treatments.
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1441597
|z Texto completo
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 13229097
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 1441597
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL4787216
|
| 994 |
|
|
|a 92
|b IZTAP
|
